IDEXX Laboratories/IDXX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.

Ticker

IDXX

Sector

Healthcare

Trading on

NASDAQ

Industry

Fish/Livestock

CEO

Jonathan Mazelsky

Employees

11,000

Headquarters

Westbrook, United States

IDXX Metrics

BasicAdvanced
$41B
Market cap
48.15
P/E ratio
$10.32
EPS
1.33
Beta
-
Dividend rate
$41B
1.3337
$583.39
$372.50
464K
1.57
1.161
39.568
60.283
48.436
41.81%
28.13%
71.91%
41.87%
48.154
11.018
26.25
39.279
51.509
8.57%
24.18%
10.59%
14.47%

What the Analysts think about IDXX

Analyst Ratings

Majority rating from 13 analysts.
Buy

IDXX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
24.42% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$964M
6.92%
Net income
$236M
21.08%
Profit margin
24.42%
13.21%

IDXX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 5.16%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.67
$2.53
$2.32
$2.81
-
Expected
$2.47
$2.37
$2.12
$2.67
$2.87
Surprise
8.19%
6.75%
9.46%
5.16%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for IDEXX Laboratories stock?

IDEXX Laboratories (IDXX) has a market cap of $41B as of June 17, 2024.

What is the P/E ratio for IDEXX Laboratories stock?

The price to earnings (P/E) ratio for IDEXX Laboratories (IDXX) stock is 48.15 as of June 17, 2024.

Does IDEXX Laboratories stock pay dividends?

No, IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders as of June 17, 2024.

When is the next IDEXX Laboratories dividend payment date?

IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders.

What is the beta indicator for IDEXX Laboratories?

IDEXX Laboratories (IDXX) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the IDEXX Laboratories stock price target?

The target price for IDEXX Laboratories (IDXX) stock is $574.49, which is NaN% below the current price of $. This is an average based on projections from 9 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell IDEXX Laboratories stock

Buy or sell IDEXX Laboratories stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing